Structures by: Gdaniec M.
Total: 209
2(C24H40O5),C12H10S2
2(C24H40O5),C12H10S2
Organic letters (2012) 14, 10 2568-2571
a=25.3117(9)Å b=7.9007(3)Å c=28.2067(10)Å
α=90.00° β=101.840(3)° γ=90.00°
2(C24H40O5),C12H10Se2
2(C24H40O5),C12H10Se2
Organic letters (2012) 14, 10 2568-2571
a=25.4161(6)Å b=7.9247(3)Å c=28.2540(8)Å
α=90.00° β=101.554(2)° γ=90.00°
2(C33H32O4),C10H8N2Te2
2(C33H32O4),C10H8N2Te2
Organic letters (2012) 14, 10 2568-2571
a=9.4185(2)Å b=9.4185(2)Å c=62.497(2)Å
α=90.00° β=90.00° γ=120.00°
N,N'-bis(2-pyridyl)-1,3-diaminobenzene 4,4'-oxybisbenzoic acid
C16H14N4,C14H10O5
Organic & Biomolecular Chemistry (2003) 1, 8 1425
a=35.743(7)Å b=9.285(2)Å c=7.3380(10)Å
α=90.00° β=90.00° γ=90.00°
N,N'-bis(2-pyridyl)-1,3-diaminobenzene 1,3-benzenedicarboxylic acid
C16H14N4,C8H6O4
Organic & Biomolecular Chemistry (2003) 1, 8 1425
a=9.1922(11)Å b=7.1341(11)Å c=31.750(4)Å
α=90.00° β=90.00° γ=90.00°
N,N'-bis(2-pyridyl)-1,3-diaminobenzene sebacic acid
C16H14N4,C10H18O4
Organic & Biomolecular Chemistry (2003) 1, 8 1425
a=5.4920(10)Å b=34.585(2)Å c=6.3180(10)Å
α=90.00° β=102.810(10)° γ=90.00°
N,N'-bis(2-pyridyl)-1,3-diaminobenzene squaric acid
C16H14N4,C4H2O4
Organic & Biomolecular Chemistry (2003) 1, 8 1425
a=7.251(4)Å b=24.325(5)Å c=9.185(3)Å
α=90.00° β=90.00° γ=90.00°
N,N'-bis(2-pyridyl)-1,3-diaminobenzene succinic acid
C16H14N4,C4H6O4
Organic & Biomolecular Chemistry (2003) 1, 8 1425
a=5.7015(5)Å b=26.821(3)Å c=6.1015(6)Å
α=90.00° β=104.708(8)° γ=90.00°
N,N'-bis(2-pyridyl)-1,3-diaminobenzene 1,4-benzeneicarboxylic acid 2:1
C16H14N4,C4H3O2
Organic & Biomolecular Chemistry (2003) 1, 8 1425
a=10.268(2)Å b=15.529(3)Å c=11.158(2)Å
α=90.00° β=105.47(3)° γ=90.00°
N,N'-bis(2-pyridyl)-1,4-diaminobenzene malonic acid co-crystal
C16H14N4,C3H4O4
Organic & Biomolecular Chemistry (2003) 1, 8 1425
a=17.290(2)Å b=4.0427(5)Å c=24.720(3)Å
α=90.00° β=93.121(11)° γ=90.00°
N,N'-bis(2-pyridyl)-1,4-diaminobenzene sebacic acid
C16H14N4,C10H18O4
Organic & Biomolecular Chemistry (2003) 1, 8 1425
a=8.4312(9)Å b=10.1438(12)Å c=15.0064(15)Å
α=85.842(9)° β=73.025(9)° γ=78.006(9)°
N,N'-bis(2-pyridyl)-1,4-diaminobenzene 1,4-benzenedicarboxylic acid
C16H14N4,C8H6O4
Organic & Biomolecular Chemistry (2003) 1, 8 1425
a=7.7670(13)Å b=8.8044(17)Å c=9.1959(17)Å
α=62.048(19)° β=71.921(17)° γ=70.707(16)°
N,N'-bis(2-pyridyl)-4,4'-oxybis(aminobenzene) 1,4-benzenedicarboxylic acid hydrate 1:1:1
C22H18N4O,C8H6O4,H2O
Organic & Biomolecular Chemistry (2003) 1, 8 1425
a=10.3442(7)Å b=11.7028(9)Å c=12.6687(9)Å
α=78.461(6)° β=65.910(6)° γ=73.925(6)°
N,N'-bis(2-pyridyl)-2,2'-oxybis(aminobenzene) fumaric acid co-crystal
C22H18N4O,0.5(C4H4O4)
Organic & Biomolecular Chemistry (2003) 1, 8 1425
a=28.8097(18)Å b=7.8866(6)Å c=18.5925(10)Å
α=90.00° β=98.004(5)° γ=90.00°
N,N'-bis(2-pyridyl)-2,2'-oxybis(aminobenzene) 1,4-benzenedicarboxylic acid co-crystal
C22H18N4O,0.5(C8H6O4)
Organic & Biomolecular Chemistry (2003) 1, 8 1425
a=8.2875(6)Å b=10.1511(8)Å c=13.3739(10)Å
α=78.828(7)° β=87.705(6)° γ=84.019(6)°
N,N'-bis(2-pyridyl)-1,4-diaminobenzene 2,2'-biphenyldicarboxylic acid co-crystal
C16H14N4,C14H10O4
Organic & Biomolecular Chemistry (2003) 1, 8 1425
a=9.117(2)Å b=14.433(4)Å c=19.312(6)Å
α=90.00° β=90.00° γ=90.00°
N,N'-bis(2-pyridyl)-1,4-diaminobenzene squaric acid co-crystal
C16H14N4,C4H2O4
Organic & Biomolecular Chemistry (2003) 1, 8 1425
a=3.8420(10)Å b=9.062(2)Å c=12.098(2)Å
α=87.23(3)° β=81.25(3)° γ=78.18(3)°
(8Z,8'Z)-1,1',6,6'-tetrahydroxy-3,3'-dimethyl-8,8'-bis((3- (morpholin-4-yl)propan-1)amino)-5,5'-di(propan-2-yl)-2,2'-binaphthalene- 7,7'(8H,8'H)-dione
C44H58N4O8
Organic & biomolecular chemistry (2010) 8, 24 5511-5518
a=37.523(3)Å b=11.2668(6)Å c=21.4820(17)Å
α=90.00° β=120.074(10)° γ=90.00°
rifampicin 1,1,1-trichloroethane solvate
C43H58N4O12,2(C2H3Cl3)
Organic & biomolecular chemistry (2012) 10, 12 2385-2388
a=10.9716(4)Å b=18.7546(6)Å c=13.2194(4)Å
α=90.00° β=101.595(3)° γ=90.00°
Rifampicin methanol trisolvate dihydrate
C43H58N4O12,2(CH4O),3(H2O)
Organic & biomolecular chemistry (2012) 10, 12 2385-2388
a=13.8494(6)Å b=17.4243(7)Å c=20.0324(9)Å
α=90.00° β=90.00° γ=90.00°
(C41H54N2O12),3(CH4O),(CH2Cl2)
(C41H54N2O12),3(CH4O),(CH2Cl2)
Organic & biomolecular chemistry (2012) 10, 12 2385-2388
a=9.2035(1)Å b=20.0206(1)Å c=13.8049(1)Å
α=90.00° β=103.152(1)° γ=90.00°
N,N'-Bis(2-pyridyl) -4,4'-oxybis(aminobenzene), polymorph alphafrom ethyl acetate
C22H18N4O
New Journal of Chemistry (2002) 26, 4 448
a=9.6437(5)Å b=11.8742(6)Å c=17.1611(8)Å
α=79.732(4)° β=89.713(4)° γ=72.535(5)°
N,N'-Bis(2-pyridyl) -4,4'-methylenebis(aminobenzene)
C23H20N4
New Journal of Chemistry (2002) 26, 4 448
a=9.756(2)Å b=17.048(3)Å c=22.116(4)Å
α=90.00° β=90.00° γ=90.00°
N,N'-Bis(2-pyridyl) -4,4'-oxybis(aminobenzene),polymorph beta from methanol
C22H18N4O
New Journal of Chemistry (2002) 26, 4 448
a=11.162(1)Å b=18.893(1)Å c=17.247(1)Å
α=90.00° β=100.89(1)° γ=90.00°
N,N'-Bis(2-pyridyl)-1,3-diaminobenzene
C16H14N4
New Journal of Chemistry (2002) 26, 4 448
a=19.917(4)Å b=7.627(2)Å c=8.677(2)Å
α=90.00° β=90.00° γ=90.00°
N,N'-Bis(2-pyridyl)-1,3-diamino-2-methylbenzene
C17H16N4
New Journal of Chemistry (2002) 26, 4 448
a=11.352(5)Å b=7.702(2)Å c=16.435(7)Å
α=90.00° β=90.36(3)° γ=90.00°
N,N'-Bis(2-pyridyl)-1,4-diaminobenzene, polymorph alpha
C16H14N4
New Journal of Chemistry (2002) 26, 4 448
a=7.778(2)Å b=9.003(2)Å c=10.240(2)Å
α=101.77(3)° β=97.54(3)° γ=105.52(3)°
N,N'-Bis(2-pyridyl)-1,4-diaminobenzene, polymorph beta
C16H14N4
New Journal of Chemistry (2002) 26, 4 448
a=7.454(1)Å b=8.991(2)Å c=19.477(4)Å
α=90.00° β=90.00° γ=90.00°
N,N'-Bis(2-pyridyl)-1,5-diaminonaphthalene
C20H16N4
New Journal of Chemistry (2002) 26, 4 448
a=8.118(2)Å b=9.361(2)Å c=11.803(2)Å
α=100.62(3)° β=101.57(3)° γ=114.20(3)°
N,N'-Bis(2-pyridyl)-4,4'-diaminobiphenyl
C22H18N4
New Journal of Chemistry (2002) 26, 4 448
a=14.761(3)Å b=13.162(3)Å c=18.341(4)Å
α=90.00° β=104.70(3)° γ=90.00°
N,N'-Bis(2-pyridyl) -4,4'-thiobis(aminobenzene)
C22H18N4S
New Journal of Chemistry (2002) 26, 4 448
a=34.619(7)Å b=18.823(4)Å c=5.6100(10)Å
α=90.00° β=90.00° γ=90.00°
N,N'-Bis(2-pyridyl)-3,3'-methylenebis(aminobenzene)
C23H20N4
New Journal of Chemistry (2002) 26, 4 448
a=11.4291(10)Å b=14.5351(13)Å c=11.9115(11)Å
α=90.00° β=107.555(8)° γ=90.00°
N,N'-Bis(2-pyridyl) -3,3'-methylenebis(aminobenzene) 0.5 ethanol solvate
C23H20N4x0.5C2H5OH
New Journal of Chemistry (2002) 26, 4 448
a=15.039(2)Å b=15.039(2)Å c=8.896(2)Å
α=90.00° β=90.00° γ=90.00°
2,3-dicyano-5,6-bis-4-(benzyloxy)phenyl pyrazine
C32H22N4O2
New J. Chem. (2017) 41, 9 3586
a=8.2968(3)Å b=11.2161(5)Å c=27.6291(10)Å
α=90° β=97.453(3)° γ=90°
2,3-Dicyano-5,6-bis-4-[3,5-bis(benzyloxy)benzyloxy]phenyl pyrazine
C60H46N4O6,2(CH2Cl2)
New J. Chem. (2017) 41, 9 3586
a=23.8249(7)Å b=15.5643(4)Å c=16.2565(4)Å
α=90° β=117.473(3)° γ=90°
Bis(R,R)-(-)-trans-2,3-bis(diphenylhydroxymethyl)-1,4-dioxaspiro(4.4)nonane N-nitroso-4-phenylpiperidine clathrate
(C33H32O4.C11H14N2O1)
Chemical Communications (1999) 15 1385
a=11.292(2)Å b=9.536(2)Å c=17.654(4)Å
α=90.00° β=97.04(2)° γ=90.00°
Bis(R,R)-(-)-trans-2,3-bis(diphenylhydroxymethyl)-1,4-dioxaspiro(4.4)nonane N-nitroso-4-benzylpiperidine 2:1 clathrate
2(C33H32O4).C12H16N2O1
Chemical Communications (1999) 15 1385
a=35.720(7)Å b=8.605(2)Å c=23.661(5)Å
α=90.00° β=117.94(3)° γ=90.00°
3,8-dimethyl-2,7-dioxo-3H,8H-pyrimido[6',5':4,5]tieno[2,3-d]pyrimidine hydrate
(C10H8N4O2S1)2.5.75H2O
J. Chem. Soc., Perkin Trans. 1 (2002) 1 53-57
a=28.330(1)Å b=12.851(1)Å c=19.354(1)Å
α=90.00° β=131.75(1)° γ=90.00°
Dithioxamide-4,4'-bipyridyl (1/1)
C10H8N2,C2H4N2S2
CrystEngComm (2008) 10, 10 1421
a=7.5110(5)Å b=8.0199(7)Å c=11.8111(11)Å
α=109.710(8)° β=93.471(7)° γ=99.100(6)°
4,4'-ethane-1,2-diyldipyridine - dithiooxamide (1/1)
C12H12N2,C2H4N2S2
CrystEngComm (2008) 10, 10 1421
a=7.3183(7)Å b=9.4645(12)Å c=11.4992(11)Å
α=66.910(11)° β=89.531(8)° γ=84.021(9)°
Dithiooxamide - 2,7-diazapyrene (1/1)
C14H8N2,C2H4N2S2
CrystEngComm (2008) 10, 10 1421
a=7.2550(8)Å b=8.7786(12)Å c=11.8824(11)Å
α=85.341(9)° β=79.117(8)° γ=83.618(10)°
1,4-diazabicyclo(2.2.2)octane - dithiooxamide (1/1)
C6H12N2,C2H4N2S2
CrystEngComm (2008) 10, 10 1421
a=15.7292(7)Å b=6.0827(3)Å c=12.5292(7)Å
α=90.00° β=101.511(6)° γ=90.00°
Dithiooxamide-1,10-phenanthroline (1/1)
C2H4N2S2,2(C12H8N2)
CrystEngComm (2008) 10, 10 1421
a=10.7438(9)Å b=10.0220(9)Å c=10.9457(10)Å
α=90.00° β=96.110(7)° γ=90.00°
1,3,5,7-tetraazatricyclo(3.3.1.13,7)decane - dithiooxamide (1/1)
C6H12N4,C2H4N2S2
CrystEngComm (2008) 10, 10 1421
a=9.7776(10)Å b=7.3250(7)Å c=17.6664(13)Å
α=90.00° β=104.485(8)° γ=90.00°
3,5-dimethylpyridine pentafluoroiodobenzene
C6F5I,C7H9N
CrystEngComm (2007) 9, 3 203
a=7.2792(5)Å b=12.9453(7)Å c=15.2214(11)Å
α=90.00° β=95.479(6)° γ=90.00°
4-methylpyridine pentafluoroiodobenzene
C6F5I,C6H7N
CrystEngComm (2007) 9, 3 203
a=7.2888(6)Å b=14.1251(11)Å c=12.6561(11)Å
α=90.00° β=95.502(7)° γ=90.00°
2,3,4,5,6-pentafluorophenol 2,3,4,5,6-pentafluoroaniline 2:1 adduct
2C6F5OH,C6F5NH2
CrystEngComm (2007) 9, 4 286
a=21.1635(16)Å b=5.6554(4)Å c=16.5577(13)Å
α=90.00° β=114.797(7)° γ=90.00°
2,3,4,5,6-pentafluorophenol
C6HF5O
CrystEngComm (2007) 9, 4 286
a=12.938(3)Å b=4.8572(13)Å c=10.010(2)Å
α=90.00° β=106.55(2)° γ=90.00°
2,4,6-trimethylpyridine pentafluoroiodobenzene
C6F5I,C8H11N
CrystEngComm (2007) 9, 3 203
a=7.5677(4)Å b=16.7343(6)Å c=11.6003(3)Å
α=90.00° β=90.00° γ=90.00°
2,6-dimethylpyridine pentafluoroiodobenzene 1/1 adduct
C6F5I,C7H9N
CrystEngComm (2007) 9, 3 203
a=7.3936(9)Å b=15.4467(19)Å c=12.0105(13)Å
α=90.00° β=90.881(10)° γ=90.00°
3,5-dimethlpyridine pentafluoroiodobenzene
C6F5I,C7H9N
CrystEngComm (2007) 9, 3 203
a=7.2401(8)Å b=15.1648(14)Å c=12.9908(12)Å
α=90.00° β=91.574(8)° γ=90.00°
2,3,4,5,6-pentafluorophenol
C6HF5O
CrystEngComm (2007) 9, 4 286
a=5.1398(9)Å b=19.0901(16)Å c=19.1520(15)Å
α=90.00° β=90.00° γ=90.00°
N,N'-dimesitylethanediamide
C20H24N2O2
CrystEngComm (2007) 9, 10 868
a=7.802(3)Å b=8.471(3)Å c=8.709(3)Å
α=114.30(4)° β=96.46(3)° γ=114.38(4)°
N,N'-bis(3,5-dimethylphenyl)ethanediamide
C18H20N2O2
CrystEngComm (2007) 9, 10 868
a=10.8750(13)Å b=4.7200(7)Å c=15.978(2)Å
α=90.00° β=107.312(11)° γ=90.00°
N,N'-diphenylethanediamide 2,3,4,5,6-pentafluorophenol 1:2
C14H12N2O2,2(C6HF5O)
CrystEngComm (2007) 9, 10 868
a=9.9263(5)Å b=5.6969(5)Å c=21.2570(13)Å
α=90.00° β=94.431(5)° γ=90.00°
N,N'-bis(2,6-dimethylphenyl)ethanediamide bis-2,3,4,5,6-pentafluorophenol
C18H20N2O2,2(C6HF5O)
CrystEngComm (2007) 9, 10 868
a=15.6385(9)Å b=6.9740(6)Å c=15.1543(10)Å
α=90.00° β=118.275(6)° γ=90.00°
N,N'-dimesitylethanediamide 2,3,4,5,6-pentafluorophenol 1:2
(C20H24N2O2)0.5C6F5OH
CrystEngComm (2007) 9, 10 868
a=6.9797(7)Å b=8.1338(7)Å c=15.0081(11)Å
α=78.383(7)° β=80.223(7)° γ=67.530(8)°
N,N'-bis(3,5-dimethylphenyl)ethanediamide bis-2,3,4,5,6-pentafluorophenol
C18H20N2O2,2(C6HF5O)
CrystEngComm (2007) 9, 10 868
a=7.0285(5)Å b=7.5525(5)Å c=13.6546(9)Å
α=91.511(5)° β=101.938(6)° γ=92.892(6)°
N,N'-bis(3,5-dimethylphenyl)ethanediamide bis-2,3,4,5,6-pentafluorobenzoic acid
(C18H20N2O2)0.5,C7F5O2H
CrystEngComm (2007) 9, 10 868
a=6.9617(10)Å b=8.3110(11)Å c=13.3819(19)Å
α=91.559(15)° β=104.416(11)° γ=92.117(11)°
N,N'-bis(2-pyridyl)-1,3-diaminobenzene oxalic acid
C16H14N4,C2H2O4
Organic & Biomolecular Chemistry (2003) 1, 8 1425
a=7.281(3)Å b=24.097(6)Å c=8.919(3)Å
α=90.00° β=90.00° γ=90.00°
N,N'-bis(2-pyridyl)-4,4'-methylenebis(aminobenzene) 1,4-benzenedicarboxylic acid ethanol 2:1:2
C23H20N4,0.5(C8H6O4),C2H6O
Organic & Biomolecular Chemistry (2003) 1, 8 1425
a=8.7830(11)Å b=10.6035(11)Å c=13.8087(15)Å
α=88.060(9)° β=87.645(9)° γ=86.861(9)°
1,4-diazabicyclo(2.2.2)octane - dithiooxamide (1/1)
C6H12N2,C2H4N2S2
CrystEngComm (2008) 10, 10 1421
a=6.0414(8)Å b=8.3514(4)Å c=12.3639(6)Å
α=77.833(4)° β=88.565(8)° γ=69.780(8)°
C45H50O10,C10H14N4,C10H4I2,2(CCl4)
C45H50O10,C10H14N4,C10H4I2,2(CCl4)
CrystEngComm (2016) 18, 31 5807
a=12.6235(2)Å b=16.2250(4)Å c=18.6220(4)Å
α=90.7497(18)° β=103.7900(18)° γ=102.4114(17)°
C67H68F8I4N4O12
C67H68F8I4N4O12
CrystEngComm (2016) 18, 31 5807
a=20.04603(13)Å b=23.88917(14)Å c=14.22073(10)Å
α=90° β=90° γ=90°
2(C45H50O10),2(C10H14N4),3(C7H8),2(C4I2)
2(C45H50O10),2(C10H14N4),3(C7H8),2(C4I2)
CrystEngComm (2016) 18, 31 5807
a=11.69920(10)Å b=14.9802(2)Å c=20.2256(3)Å
α=72.1610(10)° β=83.4890(10)° γ=73.8060(10)°
1
C32H38CuF9GdN2O12
Dalton transactions (Cambridge, England : 2003) (2004) 8 1194-1200
a=9.582(5)Å b=19.872(5)Å c=21.060(5)Å
α=90.000(5)° β=94.040(5)° γ=90.000(5)°
4
C40H32.34Cu2F9GdN4O10.17
Dalton transactions (Cambridge, England : 2003) (2004) 8 1194-1200
a=12.528(3)Å b=25.531(5)Å c=14.391(3)Å
α=90.00° β=92.48(3)° γ=90.00°
C14H14CaN2O11
C14H14CaN2O11
Dalton transactions (Cambridge, England : 2003) (2011) 40, 2 463-471
a=6.6149(13)Å b=30.137(6)Å c=8.2217(16)Å
α=90.00° β=90.14(3)° γ=90.00°
C14H22BaCoN2O16
C14H22BaCoN2O16
Dalton transactions (Cambridge, England : 2003) (2011) 40, 2 463-471
a=8.8466(3)Å b=11.3244(5)Å c=11.4821(4)Å
α=102.232(3)° β=91.490(3)° γ=106.382(3)°
C14H24CaCoN2O17
C14H24CaCoN2O17
Dalton transactions (Cambridge, England : 2003) (2011) 40, 2 463-471
a=8.8190(3)Å b=11.4750(3)Å c=11.7590(5)Å
α=86.2450(10)° β=72.7850(10)° γ=89.4840(10)°
C56H40CuN4,CuI2
C56H40CuN4,CuI2
Dalton Transactions (2013) 42, 10 3357
a=13.848(4)Å b=17.564(5)Å c=19.573(2)Å
α=90.00° β=90.00° γ=90.00°
N,N'-Bis(2-pyridyl)-4,4'-oxybis(aminobenzene) phenazine 1:2 complex
C22H18N4O,2(C12H8N2)
CrystEngComm (2005) 7, 71 433
a=7.1084(5)Å b=12.7044(7)Å c=20.4711(12)Å
α=86.329(5)° β=81.084(5)° γ=77.767(5)°
N,N'-Bis(2-pyridyl)-1,4-diaminobenzene phenazine 1:4 complex
C16H14N4,4(C12H8N2)
CrystEngComm (2005) 7, 71 433
a=9.8663(9)Å b=10.7948(9)Å c=12.5957(9)Å
α=108.446(7)° β=101.895(7)° γ=93.506(7)°
N,N'-Bis(2-pyridyl)-4,4'-sulphonyldianiline phenazine 1:1 complex
C22H18N4O2S,C12H8N2
CrystEngComm (2005) 7, 71 433
a=14.1875(8)Å b=8.7245(5)Å c=23.0060(13)Å
α=90.00° β=101.831(5)° γ=90.00°
N,N'-Bis(2-pyridyl)-1,3-diamino-2-methylbenzene phenazine 2:1
C17H16N4,0.5(C12H8N2)
CrystEngComm (2005) 7, 71 433
a=8.5174(7)Å b=8.6054(9)Å c=14.5408(11)Å
α=99.694(7)° β=93.711(6)° γ=115.471(9)°
N,N'-Diphenyl-1,4-diaminobenzene phenazine 1:1 complex
C18H16N2,C12H8N2
CrystEngComm (2005) 7, 71 433
a=5.3360(8)Å b=10.8324(17)Å c=11.4215(17)Å
α=66.689(15)° β=78.508(12)° γ=81.096(13)°
2(C33H32O4),C10H8N2Se2
2(C33H32O4),C10H8N2Se2
Organic letters (2012) 14, 10 2568-2571
a=9.2984(1)Å b=9.2984(1)Å c=124.047(1)Å
α=90.00° β=90.00° γ=120.00°
Ethyl ester of glycyrrhetinic acid
C32H50O4
Acta Crystallographica Section B (2016) 72, 4 584-592
a=12.9577(5)Å b=13.0369(4)Å c=16.3908(5)Å
α=90° β=90° γ=90°
4-etylmorpholine ester of glycyrrhetinic acid
C36H57NO5
Acta Crystallographica Section B (2016) 72, 4 584-592
a=12.87000(10)Å b=13.6972(2)Å c=18.5682(3)Å
α=90° β=90° γ=90°
Isopropyl ester of glycyrrhetinic acid
C33H52O4
Acta Crystallographica Section B (2016) 72, 4 584-592
a=11.7789(2)Å b=13.0812(3)Å c=18.7845(4)Å
α=90° β=90° γ=90°
(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-(3-carboxypropanoyloxy)- 2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b- dodecahydro-1H-picene-2-carboxylic acid propionic acid solvate
c34H50O7,C3H6O2
Acta Crystallographica Section B (2015) 71, 1
a=13.0640(3)Å b=7.3190(2)Å c=18.6170(4)Å
α=90° β=103.515(2)° γ=90°
(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-(3-carboxypropanoyloxy)- 2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b- dodecahydro-1H-picene-2-carboxylic acid
C34H50O7
Acta Crystallographica Section B (2015) 71, 1
a=7.47600(10)Å b=35.9810(5)Å c=11.3590(2)Å
α=90° β=90.9440(10)° γ=90°
(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-(3-carboxypropanoyloxy)- 2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b- dodecahydro-1H-picene-2-carboxylic acid dimethoxyethan solvate
C34H50O7,C4H10O2
Acta Crystallographica Section B (2015) 71, 1
a=7.2834(2)Å b=11.6425(3)Å c=41.9069(15)Å
α=90° β=90° γ=90°
(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-(3-carboxypropanoyloxy)- 2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b- dodecahydro-1H-picene-2-carboxylic acid : monosodium (2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-(3-carboxylatopropanoyloxy)- 2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b- dodecahydro-1H-picene-2-carboxylic acid water/butan-2-one solvate
C34H50O7,C34H49NaO7,2.0(H2O),2.0(C4H8O)
Acta Crystallographica Section B (2015) 71, 1
a=7.34970(10)Å b=11.80610(10)Å c=42.4208(4)Å
α=90° β=92.4760(10)° γ=90°
2,3,4,5,6-Pentafluorobenzamide
C7H2F5N1O1
Acta Crystallographica Section E (2003) 59, 11 o1642-o1644
a=12.7305(11)Å b=6.1929(6)Å c=9.5856(10)Å
α=90.00° β=100.073(8)° γ=90.00°
(S)-Nitrosoazetidine-2-carboxylic acid
C4H6N2O3
Acta Crystallographica Section E (2004) 60, 2 o181-o183
a=6.6521(11)Å b=7.948(2)Å c=10.848(2)Å
α=90.00° β=90.00° γ=90.00°
1H-Triazole
C6H5N3
Acta Crystallographica Section E (2005) 61, 9 o2967-o2969
a=4.2422(11)Å b=17.827(6)Å c=20.685(7)Å
α=72.63(3)° β=87.15(2)° γ=86.23(3)°
Benzimidazole-2-carboxylic acid monohydrate
C8H6N2O2,H2O
Acta Crystallographica Section E (2005) 61, 12 o4185-o4187
a=4.4080(15)Å b=8.877(3)Å c=10.757(3)Å
α=72.20(3)° β=87.67(3)° γ=88.53(3)°
1H-benzimidazole
C7H6N2
Acta Crystallographica Section E (2005) 61, 12 o4116-o4118
a=9.7257(11)Å b=16.6879(17)Å c=7.6056(11)Å
α=90.00° β=90.00° γ=90.00°
2,3,4,6-hydroquinone dihydrate
C6H2F4O2,2H2O
Acta Crystallographica Section E (2006) 62, 4 o1650-o1651
a=7.6277(9)Å b=11.9718(9)Å c=17.5010(13)Å
α=90.00° β=90.00° γ=90.00°
(4R,5R)-4,5-Diphenylimidazolidinium-2-carboxylate methanol solvate
C16H16N2O2,CH4O
Acta Crystallographica Section E (2006) 62, 8 o3271-o3273
a=5.9624(4)Å b=8.8288(6)Å c=29.4086(19)Å
α=90.00° β=90.00° γ=90.00°
Quinoxaline--hydroquinone (2/1)
2C8H6N2,C6H6O2
Acta Crystallographica Section E (2006) 62, 8 o3498-o3500
a=7.0724(9)Å b=7.2096(10)Å c=9.1803(12)Å
α=72.204(12)° β=88.516(11)° γ=85.046(11)°
(R,R)-Perhydrobenzimidazolium-2-carboxylate
C8H14N2O2
Acta Crystallographica Section E (2006) 62, 8 o3434-o3436
a=5.6176(4)Å b=9.1414(5)Å c=16.1195(7)Å
α=90.00° β=90.00° γ=90.00°
2,2'-(p-Phenylenediimino)dipyridinium dichloride hexahydrate
C16H16N42,2Cl,6H2O
Acta Crystallographica Section E (2006) 62, 8 o3319-o3321
a=8.2870(10)Å b=8.3104(10)Å c=9.1906(12)Å
α=65.572(12)° β=89.030(10)° γ=75.472(10)°
O-(2,3,4,5,6-Pentafluorobenzyl)hydroxylaminium chloride
C7H5F5NO,Cl
Acta Crystallographica Section E (2005) 61, 4 o1187-o1189
a=19.994(3)Å b=5.4020(8)Å c=9.0305(15)Å
α=90.00° β=99.939(13)° γ=90.00°
C20H19NO6
C20H19NO6
Acta Crystallographica Section C (1993) 49, 3 517-519
a=10.833(2)Å b=13.184(3)Å c=13.375(3)Å
α=89.73(3)° β=74.52(3)° γ=71.95(3)°
Bis(4,6-diaminopyrimidin-2-yl) disulfide dimethyl sufoxide disolvate
C8H10N8S2,2(C2H6OS)
Acta Crystallographica Section E (2008) 64, 9 o1724
a=11.2612(4)Å b=11.9948(5)Å c=15.0754(6)Å
α=90.00° β=90.00° γ=90.00°
Quinoxalinium 2,6-dihydroxybenzoate
C8H7N2,C7H5O4
Acta Crystallographica Section E (2007) 63, 3 o1480-o1482
a=12.0557(5)Å b=9.0755(4)Å c=24.7931(10)Å
α=90.00° β=102.872(3)° γ=90.00°
Quinoxaline--dihydroxyacetic acid (1/1)
C8H6N2,C2H4O4
Acta Crystallographica Section E (2007) 63, 7 o3081-o3081
a=4.0384(9)Å b=10.406(4)Å c=12.052(3)Å
α=88.83(2)° β=83.981(18)° γ=82.50(2)°
2-Amino-4,5-dihydro-1<i>H</i>-imidazol-3-ium 7,8-dihydroimidazo[1,2-<i>c</i>][1,3,5]thiadiazine-2,4(6<i>H</i>)-dithione(1-) dimethylformamide disolvate
C3H8N3,C5H4N3S3,2(C3H7NO)
Acta Crystallographica Section E (2007) 63, 7 o3329-o3329
a=6.8301(7)Å b=12.1321(14)Å c=12.9487(10)Å
α=79.232(7)° β=89.907(7)° γ=82.125(7)°